Последние добавленные видео:
pertuzumab
-
1 год назад
12383 1 год назад 8:31Trastuzumab (Herceptin) & Pertuzumab (Perjeta) for HER2+ Breast Cancer: A COMPLETE Guide
-
8 лет назад
183 8 лет назад 5:43Safety and Efficacy of Pertuzumab in HER2+ Breast Cancer
-
3 года назад
660 3 года назад 4:29Pertuzumab, trastuzumab and cyclophosphamide in older patients with HER2+ breast cancer
-
6 лет назад
196 6 лет назад 1:54Dr. Tripathy Discusses Pertuzumab in HER2+ Breast Cancer
-
7 лет назад
619 7 лет назад 1:16The Optimal Duration of Pertuzumab Treatment for Patients With HER2+ Breast Cancer
-
13 лет назад
2890 13 лет назад 1:31Dr. José Baselga on Combining Pertuzumab (Perjeta) with Trastuzumab (Herceptin)
-
7 лет назад
157 7 лет назад 1:13Dr. Pegram Discusses Adjuvant Pertuzumab in HER2+ Breast Cancer
-
11 лет назад
526 11 лет назад 3:57Pertuzumab as personalized therapy for breast cancer - Video abstract 37100
-
5 лет назад
3290 5 лет назад 4:31Study of Atezolizumab with Pertuzumab and Trastuzumab in HER2- Positive Metastatic Breast Cancer
-
2 года назад
478 2 года назад 1:47HER2CLIMB-05: tucatinib + trastuzumab and pertuzumab as maintenance therapy for HER2+ metastatic BC
-
7 лет назад
1427 7 лет назад 1:19Dr. Jahanzeb on the Benefit of Pertuzumab Plus Trastuzumab in HER2+ Breast Cancer
-
12 лет назад
1253 12 лет назад 2:12Dr. Pegram on Pertuzumab and Trastuzumab in Breast Cancer
-
10 месяцев назад
99 10 месяцев назад 5:58Endocrine therapy plus trastuzumab and pertuzumab shows excellent survival outcomes in HR and HE...
-
11 лет назад
2137 11 лет назад 4:34Paclitaxel With Pertuzumab Plus Trastuzumab in Metastatic Breast Cancer
-
9 лет назад
231 9 лет назад 1:28Dr. Peter Beitsch on Pertuzumab in the Luminal Subtype of HER2-Positive Breast Cancer
-
5 лет назад
1644 5 лет назад 9:05Pertuzumab plus trastuzumab and chemotherapy continues to show benefit in HER2-positive breast c...
-
5 лет назад
3577 5 лет назад 2:40CLEOPATRA: pertuzumab, trastuzumab & chemo for HER2+ mBC
-
5 лет назад
581 5 лет назад 2:06PHranceSCa: evaluating patient satisfaction with subcutaneous pertuzumab and trastuzumab treatment